Physician profile
Brian Crenshaw
NPI 1639464290
$26,249.54
in general payments reported to CMS, 2019-2025
10 companies · $40.96 in 2025
The $40.96 reported for 2025 was less than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,976 · 2020: $16K · 2021: $793 · 2022: $682 · 2023: $848 · 2024: $176 · 2025: $40.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,065.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,064.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $24,480.52 | 2019-2021 | |
| Merz North America, INC. | $687.98 | 2023 | Xeomin |
| Stimwave Technologies Incorporated | $666.79 | 2022 | |
| Heartflow, INC. | $138.63 | 2023 | Ffrct |
| Revance Therapeutics, INC. | $115.84 | 2024 | Daxxify |
| Merck Sharp & Dohme LLC | $50.53 | 2021-2025 | Bridion |
| Abbvie INC. | $43.72 | 2024-2025 | |
| Atricure, INC. | $32.69 | 2024 | |
| Boston Scientific Corporation | $21.63 | 2023 | Rhythmia Mapping System |
| Mallinckrodt Enterprises LLC | $11.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Crenshaw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.